Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Can Fulgent Genetics Stock Rebound?

TheMotleyFool

0 0

Can a diagnostics company that makes most of its money from coronavirus tests keep growing in a post-pandemic environment? Fulgent Genetics (NASDAQ: FLGT) shares are still far below their peak in February, despite reporting record revenue in the fourth quarter.

Could this stock deliver market-beating gains over the long run, or are its new shareholders setting themselves up for heartbreak once the COVID-19 vaccine supply catches up with demand? To find out where the company is headed, let's start with a quick look at its recent accomplishments.

Image source: Getty Images.

Source Fool.com

Like: 0

FLGT

Teilen